EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY by E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz

Subjects: Get full text

Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation by Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov

Subjects: “…low lipid-lowering therapy coverage…”
Get full text

EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC) by V. A. Korneva, T. Yu. Kuznetsova, N. N. Natal’ya N. Vezikova

Subjects: Get full text

Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study by Andrej Belančić, Marta Kučan Štiglić, Luka Prgomet, Ivan Pećin, Željko Reiner, Dinko Vitezić

Subjects: Get full text

Combined lipid-lowering therapy: choosing strategy and tactics by N. A. Koziolova

Subjects: “…combined lipid-lowering therapy…”
Get full text

THERAPY COMPLIANCE IN AMBULATORY PATIENTS: PROFILE REGISTRY DATA by Yu. V. Lukina, S. Yu. Martsevich, A. V. Zagrebelnyi, S. G. Tripkosh, F. A. Aidu, A. D. Deev

Subjects: Get full text

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis by N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov

Subjects: “…lipid-lowering therapy…”
Get full text

Actual issues of lipid centers’ operation in Russian Federation by S. Boytsov, A. Katapano, O. Barbarash, M. Yezhov, A. Meshkov, M. Voevoda, V. Gurevich, V. Kashtalap, D. Duplyakov, N. Vezikova, D. Sadykova

Subjects: Get full text

New methods for dyslipidemia correction by V. T. Ivashkin, O. M. Drapkina, A. V. Klimenkov

Subjects: Get full text

The potential of volatile oil farnesol as a new treatment for hypertension and improvement of vascular function in hypertensive rats by Roma Ehsan, Luciane Barbosa Pessoa, Waqas Younis, Wajiha Manzoor, Muhammad Nasir Hayat Malik, Muhammad Naveed Mushtaq, Tariq G. Alsahli, Muryam Abdul Razzaq, Francislaine Aparecida dos Reis Lívero, Arquimedes Gasparotto Junior

Subjects: Get full text

Efficient Hydrolysis of Earthworm Protein and the Lipid-Lowering Mechanism of Peptides in the Hydrolysate by Mengmeng Zhang, Xiang Mai, Shanghua Yang, Yuhua Huang, Lina Zhang, Wenbin Ren, Weidong Bai, Xuan Xin, Wenhong Zhao, Lisha Hao

Subjects: Get full text

MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) by S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina

Subjects: “…lipid-lowering therapy…”
Get full text

Improving the Use of Lipid-lowering Drugs at Brits Hospital by C. van Deventer, C. Mokhlele, J. Hugo

Subjects: Get full text

A New Insight on Atherosclerosis Mechanism and Lipid-Lowering Drugs by Penghui Li, Wei Jiang

Subjects: Get full text

Functional Characteristics and Lipid Lowering Activity of Auricularia heimuer Soluble Dietary Fiber by Xueyu SHANG, Heriban MEI, Ling SU, Qi WANG

Subjects: Get full text

Lipid-lowering drug targets associated with risk of respiratory disease: a Mendelian randomization study by Zhipeng Gong, Dongsheng Wu, Yin Ku, Congyao Zou, Lin Qiu, Xiaohu Hao, Lunxu Liu

Subjects: “…Lipid-lowering drug target…”
Get full text

Low-density lipoprotein cholesterol goal attainment and mortality in ischaemic heart disease: a two-year observational study by Ying Hui Mak, Fionn Chua, Xuan Han Koh, Vern Hsen Tan, Zhong Hui Lee, Audrey Lam, Kim Leng Tong, Colin Yeo, Weien Chow, Wann Jia Loh

Subjects: Get full text

Genetic association of lipids and lipid-lowering drug target genes with breast cancer by Tianhua Wang, Yan Yao, Xinhai Gao, Hao Luan, Xue Wang, Lijuan Liu, Changgang Sun

Subjects: Get full text

Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity by Barbara Gordon‐Kundu, Reza Peyravi, Anisha Garg, Anna Baker, Samantha Salas, Michael Levien, Kamil F. Faridi, Adam de Havenon, Harlan M. Krumholz, Kevin N. Sheth, Rachel Forman, Richa Sharma

Subjects: Get full text

Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events by Sidelnikov E, Kalich BA, Miglins ML, Multani JK, Tuly R, Hawkins K, Baber U

Subjects: Get full text